
TY  - JOUR
AU  - Choi, Judy
AU  - Polcher, Alexandra
AU  - Joas, Anke
C7  - 955E
TI  - Systematic literature review on Parkinson's disease and Childhood Leukaemia and mode of actions for pesticides
JO  - EFSA Supporting Publications
JA  - EFSA Supporting Publications
VL  - 13
IS  - 1
SN  - 2397-8325
UR  - https://doi.org/10.2903/sp.efsa.2016.EN-955
DO  - doi:10.2903/sp.efsa.2016.EN-955
SP  - 955E
KW  - Systematic Review
KW  - Parkinson Disease
KW  - Childhood Leukaemia
KW  - Pathogenesis
KW  - Chemicals
KW  - Pesticides
KW  - Adverse Outcome Pathway
PY  - 2016
ER  - 

TY  - JOUR
TI  - Invited Presentations
JO  - Nephrology
VL  - 3
IS  - S1
SN  - 1320-5358
UR  - https://doi.org/10.1111/j.1440-1797.1997.tb00554.x
DO  - doi:10.1111/j.1440-1797.1997.tb00554.x
SP  - S1
EP  - S630
PY  - 1997
ER  - 

TY  - JOUR
TI  - Short Papers
JO  - BJS (British Journal of Surgery)
JA  - Br J Surg
VL  - 104
IS  - S6
SN  - 0007-1323
UR  - https://doi.org/10.1002/bjs.10633
DO  - doi:10.1002/bjs.10633
SP  - 13
EP  - 82
PY  - 2017
ER  - 

TY  - JOUR
TI  - Poster Session 3
JO  - European Journal of Heart Failure Supplements
JA  - European Journal of Heart Failure Supplements
VL  - 10
IS  - S1
SN  - 1567-4215
UR  - https://doi.org/10.1093/eurjhf/hsr007
DO  - doi:10.1093/eurjhf/hsr007
SP  - S116
EP  - S161
PY  - 2011
ER  - 

TY  - JOUR
TI  - Speed Talks
JO  - The FEBS Journal
JA  - FEBS J
VL  - 283
IS  - S1
SN  - 1742-464X
UR  - https://doi.org/10.1111/febs.13807
DO  - doi:10.1111/febs.13807
SP  - 57
EP  - 126
PY  - 2016
ER  - 

TY  - JOUR
TI  - 6th World Congress-World Institute of Pain
JO  - Pain Practice
VL  - 12
IS  - s1
SN  - 1530-7085
UR  - https://doi.org/10.1111/j.1533-2500.2011.00528.x
DO  - doi:10.1111/j.1533-2500.2011.00528.x
SP  - 1
EP  - 199
PY  - 2012
ER  - 

TY  - JOUR
TI  - Abstracts
JO  - American Journal of Transplantation
VL  - 5
IS  - s11
SN  - 1600-6135
UR  - https://doi.org/10.1111/j.1600-6135.2005.abstracts.x
DO  - doi:10.1111/j.1600-6135.2005.abstracts.x
SP  - 155
EP  - 576
PY  - 2005
ER  - 

TY  - JOUR
TI  - ABSTRACTS—POSTERS
JO  - Alcoholism: Clinical and Experimental Research
VL  - 31
IS  - s2
SN  - 0145-6008
UR  - https://doi.org/10.1111/j.1530-0277.2007.00412.x
DO  - doi:10.1111/j.1530-0277.2007.00412.x
SP  - 9A
EP  - 248A
PY  - 2007
ER  - 

TY  - JOUR
AU  - Isaacson, Richard S.
AU  - Ganzer, Christine A.
AU  - Hristov, Hollie
AU  - Hackett, Katherine
AU  - Caesar, Emily
AU  - Cohen, Randy
AU  - Kachko, Robert
AU  - Meléndez-Cabrero, Josefina
AU  - Rahman, Aneela
AU  - Scheyer, Olivia
AU  - Hwang, Mu Ji
AU  - Berkowitz, Cara
AU  - Hendrix, Suzanne
AU  - Mureb, Monica
AU  - Schelke, Matthew W.
AU  - Mosconi, Lisa
AU  - Seifan, Alon
AU  - Krikorian, Robert
TI  - The clinical practice of risk reduction for Alzheimer's disease: A precision medicine approach
JO  - Alzheimer's & Dementia
JA  - Alzheimer's & Dementia
VL  - 14
IS  - 12
SN  - 1552-5260
UR  - https://doi.org/10.1016/j.jalz.2018.08.004
DO  - doi:10.1016/j.jalz.2018.08.004
SP  - 1663
EP  - 1673
KW  - Alzheimer’s disease prevention
KW  - Clinical precision medicine
KW  - Alzheimer’s precision medicine
KW  - Multidomain interventions
KW  - Alzheimer’s Prevention Clinic
KW  - Personalized medicine
KW  - APOE
KW  - Preclinical Alzheimer’s disease
PY  - 2018
AB  - Abstract Like virtually all age-related chronic diseases, late-onset Alzheimer's disease (AD) develops over an extended preclinical period and is associated with modifiable lifestyle and environmental factors. We hypothesize that multimodal interventions that address many risk factors simultaneously and are individually tailored to patients may help reduce AD risk. We describe a novel clinical methodology used to evaluate and treat patients at two Alzheimer's Prevention Clinics. The framework applies evidence-based principles of clinical precision medicine to tailor individualized recommendations, follow patients longitudinally to continually refine the interventions, and evaluate N-of-1 effectiveness (trial registered at ClinicalTrials.gov NCT03687710). Prior preliminary results suggest that the clinical practice of AD risk reduction is feasible, with measurable improvements in cognition and biomarkers of AD risk. We propose using these early findings as a foundation to evaluate the comparative effectiveness of personalized risk management within an international network of clinician researchers in a cohort study possibly leading to a randomized controlled trial.
ER  - 

TY  - JOUR
AU  - Kelly, Robert I
TI  - Cutaneous vasculitis and cutaneous vasculopathies
JO  - Australasian Journal of Dermatology
VL  - 36
IS  - 3
SN  - 0004-8380
UR  - https://doi.org/10.1111/j.1440-0960.1995.tb00952.x
DO  - doi:10.1111/j.1440-0960.1995.tb00952.x
SP  - 109
EP  - 119
KW  - antiphospholipid antibodies
KW  - cryoglobulinaemic vasculitis
KW  - granulomatous vasculitis
KW  - Henoch-Schönlein purpura
KW  - leukocytoclastic vasculitis
KW  - livedo vasculitis
KW  - microscopic polyarteritis
KW  - polyarteritis nodosa
KW  - pustular vasculitis
KW  - urticarial vasculitis
PY  - 1995
AB  - SUMMARY Cutaneous involvement may occur with virtually all syndromes of vasculitis. This can occur primarily as a dermatologic disorder or as a manifestation of a potentially life threatening systemic vasculitis. In this review article, classification, clinical manifestations, pathogenesis and therapy of cutaneous vasculitis will be discussed. Disorders which are primarily vascular in origin but lack a well defined inflammatory phase, referred to as ?vasculopathies? will also be discussed.
ER  - 

TY  - JOUR
TI  - Poster Sessions
JO  - Immunology
VL  - 137
IS  - s1
SN  - 0019-2805
UR  - https://doi.org/10.1111/imm.12002
DO  - doi:10.1111/imm.12002
SP  - 185
EP  - 772
PY  - 2012
ER  - 

TY  - JOUR
TI  - Abstracts
JO  - International Journal of Rheumatic Diseases
JA  - Int J Rheum Dis
VL  - 17
IS  - s1
SN  - 1756-1841
UR  - https://doi.org/10.1111/1756-185x.12344
DO  - doi:10.1111/1756-185x.12344
SP  - 1
EP  - 133
PY  - 2014
ER  - 

TY  - JOUR
TI  - Current Awareness in Contrast Media and Molecular Imaging
JO  - Contrast Media & Molecular Imaging
JA  - Contrast Media Mol Imaging
VL  - 1
IS  - 4
SN  - 1555-4309
UR  - https://doi.org/10.1002/cmmi.108
DO  - doi:10.1002/cmmi.108
SP  - 175
EP  - 182
PY  - 2006
AB  - Abstract In order to keep subscribers up-to-date with the latest developments in their field, John Wiley  2 General; Contrast Agents: 3 Chemistry; 4 Technique; 5 Experimental; 6 Applications; Molecular Imaging: 7 Carbon; 8 Fluorine; 9 Gallium; 10 Hydrogen; 11 Indium; 12 Iodine; 13 Phosphorus; 14 Technetium; 15 Others. Within each section, articles are listed in alphabetical order with respect to author. If, in the preceding period, no publications are located relevant to any one of these headings, that section will be omitted.
ER  - 

TY  - JOUR
TI  - Abstract
JO  - Journal of Thrombosis and Haemostasis
JA  - Journal of Thrombosis and Haemostasis
VL  - 5
IS  - S2
SN  - 1538-7933
UR  - https://doi.org/10.1111/j.1538-7836.2007.tb00020.x
DO  - doi:10.1111/j.1538-7836.2007.tb00020.x
SP  - P-M-501
EP  - P-M-701
PY  - 2007
ER  - 

TY  - JOUR
AU  - Vamvakas, E.C.
AU  - Carven, J.H.
TI  - Transfusion and postoperative pneumonia in coronary artery bypass graft surgery: effect of the length of storage of transfused red cells
JO  - Transfusion
VL  - 39
IS  - 7
SN  - 0041-1132
UR  - https://doi.org/10.1046/j.1537-2995.1999.39070701.x
DO  - doi:10.1046/j.1537-2995.1999.39070701.x
SP  - 701
EP  - 710
KW  - CABG = coronary artery bypass graft
KW  - RBC(s) = red cell(s)
KW  - RCT(s) randomized controlled trials
KW  - UTI(s) = urinary tract infection(s)
KW  - WBC(s) = white cells
PY  - 1999
AB  - BACKGROUND: Various bioactive substances are released from white cell (WBC) granules into red cell (RBC) components in a time-dependent manner during blood storage. Some of these substances may have immunosuppressive effects and may contribute to transfusion-induced immunomodulation. RBCs transfused after prolonged storage may be associated with a higher incidence of postoperative infections than fresh RBCs. This hypothesis does not seem to have been investigated in a clinical study. STUDY DESIGN AND METHODS: The records of 416 consecutive patients undergoing coronary artery bypass graft operations at the Massachusetts General Hospital were reviewed. The association between the length of storage of the transfused RBCs, as well as the number of units of non-WBC-reduced allogeneic RBCs and/or platelets transfused, and the occurrence of postoperative pneumonia was calculated by logistic regression analyses adjusting for the effects of confounding factors. Among these were the numbers of days of intubation, days of impaired consciousness, and units of RBCs transfused. RESULTS: By Centers for Disease Control and Prevention criteria, pneumonia developed in 54 patients (13.0%). Among 269 patients given RBCs, the risk of pneumonia increased by 1 percent per day of increase in the mean storage time of the transfused RBCs (p<0.005). In an analysis of all patients, the risk of pneumonia increased by 5 percent per unit of non-WBC-reduced allogeneic RBCs and/or platelets received (p = 0.0584). CONCLUSION: After adjustment for the effects of the risk factors for pneumonia and the number of transfused RBCs, an association was observed between the length of storage of transfused RBCs and the development of postoperative pneumonia. This association should be investigated further in future studies of the outcomes of blood transfusion.
ER  - 

TY  - JOUR
TI  - Invited Speakers
JO  - Mycoses
VL  - 55
IS  - s4
SN  - 0933-7407
UR  - https://doi.org/10.1111/j.1439-0507.2012.02204.x
DO  - doi:10.1111/j.1439-0507.2012.02204.x
SP  - 1
EP  - 56
PY  - 2012
ER  - 

TY  - JOUR
TI  - POSTER SESSIONS
JO  - Allergy
VL  - 63
IS  - s88
SN  - 0105-4538
UR  - https://doi.org/10.1111/j.1398-9995.2008.01760.x
DO  - doi:10.1111/j.1398-9995.2008.01760.x
SP  - 158
EP  - 611
PY  - 2008
ER  - 

TY  - JOUR
TI  - Subspeciality: Cardiovacular medicine
JO  - European Journal of Clinical Investigation
VL  - 31
IS  - s1
SN  - 0014-2972
UR  - https://doi.org/10.1111/j.1365-2362.2001.00001.x
DO  - doi:10.1111/j.1365-2362.2001.00001.x
SP  - 1
EP  - 44
PY  - 2001
ER  - 

TY  - JOUR
TI  - 47th Annual Meeting of the German Society for Immunology, 12–15 September, 2017, Erlangen, Germany
JO  - European Journal of Immunology
JA  - Eur. J. Immunol.
VL  - 47
IS  - S2
SN  - 0014-2980
UR  - https://doi.org/10.1002/eji.201770300
DO  - doi:10.1002/eji.201770300
SP  - 1
EP  - 333
PY  - 2017
ER  - 

TY  - JOUR
TI  - Abstract
JO  - Transfusion Medicine
VL  - 5
IS  - s1
SN  - 0958-7578
UR  - https://doi.org/10.1111/j.1365-3148.1995.tb00282.x
DO  - doi:10.1111/j.1365-3148.1995.tb00282.x
SP  - 1
EP  - 55
PY  - 1995
ER  - 
